SS Innovations International (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events

At a glance

Company: SS Innovations International
Ticker: NASDAQ: SSII
Announcement: Event
Location: Barcelona, Spain, and India

Key figures

Distance between surgeon and patient: approximately 7,500 miles
Additional telesurgeries at the India conference: Four
Reported telesurgeries as of October 23, 2026: 205
Targeted 510(k) review completion: first quarter of 2027

People

Dr. Sudhir SrivastavaChairman and Chief Executive Officer

Products and programs

SSi Mantra surgical robotic system
SSi MantrAsana tele-surgeon console

The company demonstrated its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026.
At the European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient approximately 7,500 miles away in Bengaluru, India.
Four additional robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures.
The company reported 205 telesurgeries performed with the SSi Mantra system as of October 23, 2026, including cardiac procedures.
The demonstrations highlight the potential for remote robotic surgery to extend specialist expertise beyond major medical centers, although widespread adoption depends on clinical validation, connectivity and regulatory requirements.
SS Innovations is pursuing U.S. Food and Drug Administration clearance for the SSi Mantra, with completion of the 510(k) review targeted for the first quarter of 2027; the timeline remains subject to the FDA’s review.

SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its surgical robotics platform in a series of remote operations during October medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient (https://ibn.fm/EZFDT).

The demonstrations featured the company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console. At the 40th European Association for Cardio-Thoracic Surgery (“EACTS”) annual meeting in Barcelona, SS Innovations Chairman and Chief Executive Officer Dr. Sudhir Srivastava remotely performed an atrial septal defect procedure on a patient at…

In brief

SS Innovations International says it demonstrated its SSi Mantra robotic surgery system and SSi MantrAsana tele-surgeon console at medical conferences in Spain and India during October 2026. At the European Association for Cardio-Thoracic Surgery meeting in Barcelona, CEO Dr. Sudhir Srivastava remotely performed an atrial septal defect operation on a patient in Bengaluru, about 7,500 miles away. The company also reported four other telesurgeries, performed or shown, at the Society of Robotic Surgery India conference, spanning several surgical specialties. It said 205 telesurgeries had been completed using the SSi Mantra by October 23, including cardiac operations. The company is seeking U.S. FDA clearance for the system and targets completing its 510(k) review in the first quarter of 2027, subject to the agency’s review.

Key takeaways

A remote cardiac procedure connected a surgeon in Barcelona with a patient in Bengaluru, India.
The company reported four additional telesurgeries performed or broadcast at an India conference.
SS Innovations reported 205 SSi Mantra telesurgeries as of October 23, 2026.
The company is pursuing FDA clearance, with its 510(k) review completion targeted for the first quarter of 2027.

SEC filings

Earlier from SS Innovations International

Back to News Center

SS Innovations International (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events